Epidemiologic evaluation of clinical outcomes in ethnic minorities with myelodysplastic syndromes

Leukemia Research - Tập 119 - Trang 106907 - 2022
Alfonso Molina1, Lan Xiao2, Quinn T. Ostrom3, Lisa G. Rosas2, Peter L. Greenberg4
1Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States of America
2Department of Epidemiology and Population Health, Stanford University, Stanford, CA, United States of America
3Department of Neurosurgery and Preston Robert Tisch Brain Tumor Center, Duke University School of Medicine, Durham, NC, United States of America
4Stanford Cancer Institute, Division of Hematology, Stanford University School of Medicine, Stanford, CA, United States of America

Tài liệu tham khảo

Greenberg, 2012, Revised International Prognostic Scoring System (IPSS-R) for Myelodysplastic Syndromes, Blood, 120, 2454, 10.1182/blood-2012-03-420489

Hellström-Lindberg, 2020, Myelodysplastic syndromes: moving towards personalized management, Haematologica, 105, 1765, 10.3324/haematol.2020.248955

King, 2007, Medical Management of Vulnerable and Underserved Patients: Principles, Practice, and Populations, N. Y., NY: McGraw-Hill Educ. Med.

Wang, 2012, The impact of hypomethylating agents on the cost of care and survival of elderly patients with myelodysplastic syndromes, Leuk. Res., 36, 1370, 10.1016/j.leukres.2012.07.020

Greenberg, 2008, The costs of drugs used to treat Myelodysplastic Syndromes following National Comprehensive Cancer Network guidelines, J. Natl. Comp. Cancer Netw., 6, 942, 10.6004/jnccn.2008.0072

Bauman KJ. US Census Educational Attainment 2016. https://www.census.gov/data/tables/2016/demo/education-attainment/cps-detailed-tables.html. Accessed 12 January 2021.

Carr, 2018, Occupational and educational inequalities in exit from employment at older ages: evidence from seven prospective cohorts, Occup. Environ. Med, 75, 369, 10.1136/oemed-2017-104619

Knoble, 2016, Socioeconomic status (SES) and childhood acute myeloid leukemia (AML) mortality risk: Analysis of SEER data, Cancer Epidemiol., 44, 101, 10.1016/j.canep.2016.07.007

Kirtane, 2017, Racial and ethnic disparities in hematologic malignancies, Blood, 130, 1699, 10.1182/blood-2017-04-778225

Sridharan, 2014, Epidemiologic study of myelodysplastic syndromes in a multiethnic, inner city cohort, Exp. Hematol. Oncol., 3

Zandberg, 2013, Tertiary center referral patterns for patients with myelodysplastic syndrome are indicative of age and race disparities: a single-institution experience, Leuk. Lymphoma, 54, 304, 10.3109/10428194.2012.710904

Komrokji, 2010, Outcome of patients with myelodysplastic syndromes in the Veterans Administration population, Leuk. Res., 34, 59, 10.1016/j.leukres.2009.03.022

Ye, 2019, The incidence, risk factors, and survival of acute myeloid leukemia secondary to myelodysplastic syndrome: A population-based study, Hematol. Oncol., 37, 438, 10.1002/hon.2660

Ma, 2007, Myelodysplastic syndromes: incidence and survival in the United States, Cancer, 109, 1536, 10.1002/cncr.22570

Surveillance, Epidemiology, and End Results (SEER) Program. www.seer.cancer.gov. Accessed 01 August 2020.

Fabrigar, 1999, Evaluating the use of exploratory factor analysis in psychological research, Psychol. Methods, 4, 272, 10.1037/1082-989X.4.3.272

Kaiser, 1960, The Application of Electronic Computers to Factor Analysis, Educ. Psychol. Meas., 20, 141, 10.1177/001316446002000116

Guttman, 1954, Some necessary conditions for common-factor analysis, Psychometrika, 19, 149, 10.1007/BF02289162

Bernstein, 1981, Estimation of the proportional hazard in two-treatment-group clinical trials, Biometrics, 37, 513, 10.2307/2530564

Ramadan, 2016, Racial Disparities in Patients with Myelodysplastic Syndrome (MDS): Clinical and Molecular Depiction [abstract], Blood, 128, 1997, 10.1182/blood.V128.22.1997.1997

Cella, 1991, Socioeconomic status and cancer survival, J. Clin. Oncol., 9, 1500, 10.1200/JCO.1991.9.8.1500

Landale, 2006, Hispanic Families in the United States: Family Structure and Process in an Era of Family Change

Brierley, 2020, Low participation rates and disparities in participation in interventional clinical trials for myelodysplastic syndromes, Cancer, 126, 4735, 10.1002/cncr.33105

Wang, 2009, Neighborhood socioeconomic status influences the survival of elderly patients with myelodysplastic syndromes in the United States, Cancer Causes Control, 20, 1369, 10.1007/s10552-009-9362-7

Powers, 2012, Hematologic complications, healthcare utilization, and costs in commercially insured patients with myelodysplastic syndrome receiving supportive care, Am. Health Drug Benefits, 5, 455

Stone, 2015, Place as a predictor of health insurance coverage: A multivariate analysis of counties in the United States, Health Place, 34, 207, 10.1016/j.healthplace.2015.03.015

Nazha, 2017, Differences in genomic patterns and clinical outcomes between African-American and White patients with myelodysplastic syndromes, Blood Cancer J., 7, 10.1038/bcj.2017.82

Miyazaki, 2018, Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDS, Leuk. Res., 73, 51, 10.1016/j.leukres.2018.08.022

Rollison, 2008, Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs, Blood, 112, 10.1182/blood-2008-01-134858

Thông tin
Thông tin xuất bản

Leukemia Research

Tập 119

106907

Thông tin tác giả